IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 66 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2014 | $498,000 | – | 121,965 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,663,845 | $21,013,000 | 1.13% |
| HealthCor Management, L.P. | 1,335,000 | $4,953,000 | 0.25% |
| Baker Brothers Advisors | 6,970,902 | $25,862,000 | 0.23% |
| Palo Alto Investors LP | 1,226,748 | $4,551,000 | 0.20% |
| WALL STREET ASSOCIATES | 500,000 | $1,855,000 | 0.18% |
| NATIXIS | 3,148,916 | $11,682,000 | 0.16% |
| MYCIO WEALTH PARTNERS, LLC | 200,000 | $742,000 | 0.14% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 371,759 | $1,379,000 | 0.12% |
| HOLLENCREST CAPITAL MANAGEMENT | 177,570 | $659,000 | 0.10% |
| CARL DOMINO INC | 32,137 | $119,000 | 0.08% |